Glucose News and Research

RSS

Pitt researcher to explore the neurological sex-based divide in dementia

Fifty million people worldwide are living with dementia, a broad term for diseases and conditions characterized by progressive cognitive decline.

28 May 2020

Scientists use microneedle patches to extract the skin’s interstitial fluid

The interstitial fluid is a major component of the liquid environment in the body and fills the spaces between the body's cells.

27 May 2020

Blood test could help doctors identify patients at risk of developing type 2 diabetes

Scientists have identified metabolites in the blood that accurately predict whether a woman will develop type 2 diabetes after experiencing a transient form of illness during pregnancy.

22 May 2020

High pre-pregnancy glucose levels linked to adverse outcomes even in non-diabetic women

An elevated pre-pregnancy hemoglobin A1c--which measures average blood glucose concentration--is associated with a higher risk of adverse pregnancy outcomes even in women without known diabetes, according to a new study published this week in PLOS Medicine by Joel Ray of ICES and the University of Toronto, Canada, and colleagues.

22 May 2020

Drug combination could eliminate side effects of largely abandoned diabetes treatment

A new UT Southwestern study shows how an effective but largely abandoned treatment for Type 2 diabetes could be used again in combination with another drug to eliminate problematic side effects.

20 May 2020

Study shows dairy products are linked to lower risks of diabetes and high blood pressure

Researchers have found in a large study that having at least two servings of dairy products can lower the risk of getting diabetes and high blood pressure as well as metabolic syndrome. Metabolic syndrome is a mixture of more than one condition that raises the risk of getting cardiovascular diseases.

18 May 2020

Transition to virtual care during COVID-19 does not limit glycemic outcomes of diabetes inpatients

Data collected over a 15-week period showed that using virtual care to manage diabetes patients in the hospital does not have a negative impact on their glycemic outcomes.

15 May 2020

Repurposed drug normalizes body weight, reverses metabolic damage in obese mice

An off-label experiment in mice using disulfiram, which has been used to treat alcohol use disorder for more than 50 years, consistently normalized body weight and reversed metabolic damage in obese middle-aged mice of both sexes.

14 May 2020

Potential targets discovered for COVID-19 therapy

A team of biochemists and virologists at Goethe University and the Frankfurt University Hospital were able to observe how human cells change upon infection with SARS-CoV-2, the virus causing COVID-19 in people.

14 May 2020

A deep look into hormone-producing cells of the gut

Researchers from the Hubrecht Institute and Utrecht University generated an in-depth description of the human hormone-producing cells of the gut, in a large collaborative effort with other research teams. The results are presented in the scientific journal Cell on the 13th of May.

13 May 2020

C-Path, Provention Bio collaborate to improve scientific community's insight into type 1 diabetes

The Critical Path Institute and Provention Bio, Inc. are proud to announce their collaboration to significantly improve the scientific community's insight into type 1 diabetes through Provention's contribution of data from the Phase III Protégé study of teplizumab to the T1D Trial Outcome Measures Initiative integrated database.

13 May 2020

New weight loss amphetamine could potentially avoid harmful side effects

Despite being officially declared a chronic disease there are very few long-lasting and cost-effective treatments for obesity. Amphetamines are one of the few and they reportedly act in the brain to reduce appetite and increase locomotion or stamina.

13 May 2020

Scientists develop new method to synthesize cotylenin A

Scientists at Waseda University succeeded in developing a method for a total synthesis of cotylenin A, a plant growth regulator which has attracted considerable attention from the scientific community due to its promising bioactivity as an anti-cancer agent.

13 May 2020

Experimental two-in-one diabetes shot provides better blood sugar control

The number of people with diabetes has increased from 108 million in 1980 to a staggering 422 million in 2014. In 2016, an estimated 1.6 million deaths were directly caused by diabetes, while another 2.2 million deaths were tied to high blood glucose.

12 May 2020

Transcranial direct current stimulation does not affect metabolism, study shows

Transcranial direct current stimulation, tDCS, is a promising treatment for conditions such as depression and addictive disorders.

12 May 2020

Insulins sold at U.S. retail pharmacies are consistent with product labeling, finds study

JDRF, the American Diabetes Association (ADA), and The Leona M. and Harry B. Helmsley Charitable Trust, announce the results of a study examining the consistency and potency of insulin purchased at U.S. retail pharmacies.

12 May 2020

Single-cell RNA-seq addresses key question in islet cell biology and diabetes research

The pancreas is an abdominal organ that produces digestive enzymes as well as hormones that regulate blood sugar levels. This hormone-producing function is localized to the islets of Langerhans, which constitute clusters of different endocrine cell types.

12 May 2020

New two-in-one shot could make it easier for diabetics to control their blood sugar

A Stanford research team has developed a way to boost the effectiveness of the insulin injections people with diabetes routinely take to control their blood sugar.

11 May 2020

Urbanization in India may be associated with increase in cardiometabolic risk factors

Although the health benefits of green space are supported by a growing body of evidence, few studies on this topic have been carried out in low- and middle-income countries.

11 May 2020

Telehealth during COVID-19 could help avoid admissions for diabetic ketoacidosis

A new study has shown that for some patients with type 1 diabetes the close monitoring of their condition using telehealth protocols combined with appropriate technology may lead to better care during the COVID-19 pandemic, when patients are avoiding in-person visits.

11 May 2020

Glucose News and Research

Pitt researcher to explore the neurological sex-based divide in dementia

Scientists use microneedle patches to extract the skin’s interstitial fluid

Blood test could help doctors identify patients at risk of developing type 2 diabetes

High pre-pregnancy glucose levels linked to adverse outcomes even in non-diabetic women

Drug combination could eliminate side effects of largely abandoned diabetes treatment

Study shows dairy products are linked to lower risks of diabetes and high blood pressure

Transition to virtual care during COVID-19 does not limit glycemic outcomes of diabetes inpatients

Repurposed drug normalizes body weight, reverses metabolic damage in obese mice

Potential targets discovered for COVID-19 therapy

A deep look into hormone-producing cells of the gut

C-Path, Provention Bio collaborate to improve scientific community's insight into type 1 diabetes

New weight loss amphetamine could potentially avoid harmful side effects

Scientists develop new method to synthesize cotylenin A

Experimental two-in-one diabetes shot provides better blood sugar control

Transcranial direct current stimulation does not affect metabolism, study shows

Insulins sold at U.S. retail pharmacies are consistent with product labeling, finds study

Single-cell RNA-seq addresses key question in islet cell biology and diabetes research

New two-in-one shot could make it easier for diabetics to control their blood sugar

Urbanization in India may be associated with increase in cardiometabolic risk factors

Telehealth during COVID-19 could help avoid admissions for diabetic ketoacidosis

Industry Focus eBook - Cell biology (5th edition) eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News